CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents
To the Editor: Patients diagnosed with acute myeloid leukemia (AML) who are ineligible for intensive treatment with high-dose chemotherapy (IC) and subsequent stem cell transplantation…
